2014 Breast Cancer Vaccine shows promise in small clinical trial

A breast cancer vaccine designed by researchers at WUSTL is safe in patients with metastatic breast cancer

Credit: Robert Boston
A breast cancer vaccine designed by researchers at WUSTL is safe in patients with metastatic breast cancer. Preliminary evidence from the small clinical trial, led by William Gillanders, MD, also suggests the vaccine helped slow the cancer’s progression.

A breast cancer vaccine developed at Washington University School of Medicine in St. Louis is safe in patients with metastatic breast cancer, results of an early clinical trial indicate. Preliminary evidence also suggests that the vaccine primed the patients’ immune systems to attack tumor cells and helped slow the cancer’s progression.

The new vaccine causes the body’s immune system to home in on a protein called mammaglobin-A, found almost exclusively in breast tissue. The protein’s role in healthy tissue is unclear, but breast tumors express it at abnormally high levels, past research has shown.

Sources and more information:

  • Breast cancer vaccine shows promise in small clinical trial, WUSTLnews, December 1, 2014.
  • Safety and Preliminary Evidence of Biologic Efficacy of a Mammaglobin-A DNA Vaccine in Patients with Stable Metastatic Breast Cancer, Clinical Cancer Research, December 1, 2014 20:5964-5975.

Author: DES Daughter

Activist, blogger and social media addict committed to shedding light on a global health scandal and dedicated to raise DES awareness.

Have your say! Share your views

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.